28 Jun 2017 - 4:50pm

Call us: +44 (0) 207 754 0050

Press Releases in Pharmaceuticals

Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%

[PRESSWIRE] DUBLIN, May 23, 2017 -- Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced that Emmy®and Tony® award-winning actress and singer, Kristin Chenoweth will kick off the "Less Red, More You" campaign today at an exclusive event in New York City.

World’s first combination of CurQfen® and Turmacin® for the most fast acting, long lasting superior Curcumin supplement on the market

[PRESSWIRE] Calgary, Alberta, Canada - 27 March, 2017 -- Developed by AOR, Curcumin Ultra combines superior free-form curcumin (CurQfen®) with water-soluble turmeric polysaccharides (Turmacin®) for a long lasting synergistic effect for inflammation and pain relief.

Novogen Awarded Grant of up to A$3m by Australian Federal Government for Novel Drug Discovery Program

[PRESSWIRE] SYDNEY, March 6, 2017 --Australian oncology-focused biotechnology company Novogen Limited (ASX: NRT; NASDAQ: NVGN) is pleased to announce that it has been awarded a grant of up to A$3m over three years under the Cooperative Research Centre Project (CRC-P) scheme managed by the Australian Department of Industry Innovation and Science (DIIS).

Cavion to Present Clinical Trial Preliminary Results at ASTRO

[PRESSWIRE] CHARLOTTESVILLE, Va. - 26 September, 2016 -- Cavion LLC, a pharmaceutical company developing T-type calcium channel (Cav3) inhibitors for the treatment of oncologic and neurologic diseases, announced today that Ranjit Bindra, MD, PhD and Nataniel Lester-Coll, MD will present preliminary results from an ongoing Yale University Cancer Center and Cavion-sponsored Phase 1 clinical trial at the Annual Meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO) being held in Boston, Massachusetts, September 25-28.

AOR’s NEW RED YEAST RICE FORMULA RYR ANKASCIN -568-R™ OFFERS THE CARDIOVASCULAR HEALTH BENEFITS OF STATINS BUT WITHOUT THE SIDE EFFECTS

[PRESSWIRE] Calgary, Alberta, Canada - September 20, 2016 -- Developed by AOR, RYR Ankascin -568-R™ is the Only Patented, Clinically Studied, Regulatory Compliant, and Commercially Available Red Yeast Rice Extract Free of Monacolin K.

Pages

Subscribe to Press Releases in Pharmaceuticals